Target therapy in metastatic pheochromocytoma: current perspectives and controversies
about
NVP-AUY922, a novel HSP90 inhibitor, inhibits the progression of malignant pheochromocytoma in vitro and in vivo.Additive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling PathwaysMetastatic pheochromocytoma and paraganglioma.The role of miRNAs in the pheochromocytomas.
P2860
Target therapy in metastatic pheochromocytoma: current perspectives and controversies
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Target therapy in metastatic pheochromocytoma: current perspectives and controversies
@ast
Target therapy in metastatic pheochromocytoma: current perspectives and controversies
@en
Target therapy in metastatic pheochromocytoma: current perspectives and controversies
@nl
type
label
Target therapy in metastatic pheochromocytoma: current perspectives and controversies
@ast
Target therapy in metastatic pheochromocytoma: current perspectives and controversies
@en
Target therapy in metastatic pheochromocytoma: current perspectives and controversies
@nl
prefLabel
Target therapy in metastatic pheochromocytoma: current perspectives and controversies
@ast
Target therapy in metastatic pheochromocytoma: current perspectives and controversies
@en
Target therapy in metastatic pheochromocytoma: current perspectives and controversies
@nl
P2093
P2860
P356
P1433
P1476
Target therapy in metastatic pheochromocytoma: current perspectives and controversies
@en
P2093
Amrallah A. Mohammed
Ayman M. El-Shentenawy
Hani M. El-Khatib
Mohamed A. Sherisher
P2860
P356
10.4081/ONCOL.2014.249
P407
P577
2014-09-23T00:00:00Z